Northwell, New Hyde Park, New York.
Department of Medicine, Zucker School of Medicine at Hofstra/Northwell, Northwell, Hempstead, New York.
JAMA Intern Med. 2024 Jul 1;184(7):778-785. doi: 10.1001/jamainternmed.2024.0736.
Oropharyngeal dysphagia is common in hospitalized patients with Alzheimer disease and related dementias (ADRD). Although the use of thick liquids in patients with dysphagia has been shown to reduce aspiration on direct visualization, there is no clear evidence that this practice translates into improved clinical outcomes.
To determine whether a diet of thick liquids compared with thin liquids is associated with improved outcomes in hospitalized patients with ADRD and dysphagia.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study included adults aged 65 years and older with ADRD who were admitted to the medicine service across 11 diverse hospitals in New York between January 1, 2017, and September 20, 2022, with clinical suspicion of dysphagia during hospitalization and survival for at least 24 hours after hospital arrival. Patients were grouped according to whether at least 75% of their hospital diet consisted of a thick liquid diet or a thin liquid diet. Propensity score matching was used to balance covariates across the 2 groups for the following covariates: demographics (eg, age, sex), baseline clinical characteristics (eg, Charlson Comorbidity Index), and acute presentation (eg, respiratory diagnosis, illness severity, delirium).
Hospital outcomes included mortality (primary outcome), respiratory complications (eg, pneumonia), intubation, and hospital length of stay (LOS).
Of 8916 patients with ADRD and dysphagia included in the propensity score matched analysis, the mean (SD) age was 85.7 (8.0) years and 4829 were female (54.2%). A total of 4458 patients receiving a thick liquid diet were matched with 4458 patients receiving a thin liquid diet. There was no significant difference in hospital mortality between the thick liquids and thin liquids groups (hazard ratio, 0.92; 95% CI, 0.75-1.14]; P = .46). Compared with patients receiving thin liquids, patients receiving thick liquids were less likely to be intubated (odds ratio [OR], 0.66; 95% CI, 0.54-0.80), but they were more likely to have respiratory complications (OR, 1.73; 95% CI, 1.56-1.91).
This cohort study emphasizes the need for prospective studies that evaluate whether thick liquids are associated with improved clinical outcomes in hospitalized patients with ADRD and dysphagia.
口咽吞咽困难在患有阿尔茨海默病和相关痴呆症(ADRD)的住院患者中很常见。尽管已经证明在吞咽困难患者中使用浓稠液体可以减少直接可视化时的吸入,但尚无明确证据表明这种做法会转化为改善临床结局。
确定与稀薄液体相比,浓稠液体饮食是否与患有 ADRD 和吞咽困难的住院患者的改善结局相关。
设计、地点和参与者:这项队列研究纳入了 2017 年 1 月 1 日至 2022 年 9 月 20 日期间在纽约的 11 家不同医院内科服务部门住院的年龄在 65 岁及以上且患有 ADRD 的成年人,他们在住院期间出现吞咽困难的临床怀疑,并在入院后至少存活 24 小时。根据他们的住院饮食中至少 75%是浓稠液体饮食还是稀薄液体饮食,将患者分为两组。使用倾向评分匹配来平衡两组之间的协变量,这些协变量包括人口统计学特征(例如,年龄、性别)、基线临床特征(例如,Charlson 合并症指数)和急性表现(例如,呼吸诊断、疾病严重程度、谵妄)。
医院结局包括死亡率(主要结局)、呼吸并发症(例如,肺炎)、插管和住院时间( LOS)。
在纳入倾向评分匹配分析的 8916 例患有 ADRD 和吞咽困难的患者中,平均(SD)年龄为 85.7(8.0)岁,4829 例为女性(54.2%)。共 4458 例接受浓稠液体饮食的患者与 4458 例接受稀薄液体饮食的患者相匹配。浓稠液体组和稀薄液体组的院内死亡率无显著差异(风险比,0.92;95%CI,0.75-1.14];P=0.46)。与接受稀薄液体的患者相比,接受浓稠液体的患者插管的可能性较小(比值比[OR],0.66;95%CI,0.54-0.80),但发生呼吸并发症的可能性更大(OR,1.73;95%CI,1.56-1.91)。
这项队列研究强调需要进行前瞻性研究,以评估浓稠液体是否与患有 ADRD 和吞咽困难的住院患者的临床结局改善相关。